Halozyme Therapeutics | HALO - Employees Total Number

Stock Price
65.40
Daily Change
1.80 2.83%
Monthly
-4.02%
Yearly
7.83%
Q2 Forecast
62.55

Halozyme Therapeutics reported 350 in Employees for its fiscal year ending in December of 2024.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amarin 275 90 Dec/2023
Amgen 28K 1.3K Dec/2024
Baxter International 38K 22K Dec/2024
Cara Therapeutics 55 51 Dec/2023
Cytokinetics 498 75 Dec/2024
DBV Technologies USD 104 19 Dec/2023
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Halozyme Therapeutics 350 23 Dec/2024
Intrexon 202 7 Dec/2023
Ionis Pharmaceuticals 1.07K 142 Dec/2024
MannKind 407 7 Dec/2024
Minerva Neurosciences 9 0 Dec/2023
Nektar Therapeutics 137 79 Dec/2023
Pfizer 81K 7K Dec/2024
Rigel Pharmaceuticals 147 8 Dec/2023
United Therapeutics 1.3K 137 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023